ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,246.68
0.48%
Dow Jones
39,558.11
0.32%
US Dollar vs MXN
16.8412
-0.04%
Brent Oil
82.725
0.21%
Bitcoin
61,881.58
0.54%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) Noticias

NKTX Nkarta Inc

6.55
-0.03 (-0.46%)
14 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nkarta Inc NKTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.03 -0.46% 6.55 18:48:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.69 6.31 6.785 6.55 6.58
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202415:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:04EDGAR2Form 8-K - Current report
09/5/202415:01GLOBENkarta Reports First Quarter 2024 Financial Results and..
03/4/202415:02GLOBENkarta to Participate in Upcoming Investor Conferences
25/3/202405:30GLOBENkarta Announces Pricing of $240 Million Underwritten..
21/3/202415:01GLOBENkarta Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:32EDGAR2Form 144 - Report of proposed sale of securities
28/2/202407:01GLOBENkarta to Participate in Upcoming Investor Conferences
14/2/202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:20EDGAR2Form 144 - Report of proposed sale of securities
09/2/202405:38EDGAR2Form SC 13D/A - General statement of acquisition of..
18/1/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:50EDGAR2Form 8-K - Current report
03/1/202415:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/12/202319:31GLOBENkarta Presents NKX101 Clinical Data at the 2023 American..
13/11/202307:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/11/202315:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:06EDGAR2Form 8-K - Current report
09/11/202315:02GLOBENkarta Reports Third Quarter 2023 Financial Results and..
07/11/202307:02GLOBENkarta to Participate at Upcoming Investor Conferences
27/10/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/10/202311:00DJNNkarta's Stock Climbs 28% After FDA Approves Drug..
17/10/202310:47PRNUSLupus Therapeutics Announces Partnership to Support the..
17/10/202306:06EDGAR2Form 8-K - Current report
17/10/202306:01GLOBENkarta Receives FDA Clearance of IND Application for NKX019..
16/10/202315:07EDGAR2Form 8-K - Current report
16/10/202315:01GLOBENkarta to Host Conference Call on Tuesday, October 17 at 8am..
23/8/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:05EDGAR2Form 8-K - Current report
10/8/202306:01GLOBENkarta Reports Second Quarter 2023 Financial Results and..
03/8/202307:02GLOBENkarta to Participate at Upcoming Investor Conference
05/7/202315:09EDGAR2Form 8-K - Current report
05/7/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:02GLOBENkarta Appoints Alyssa Levin Chief Financial and Business..
27/6/202306:01GLOBENkarta Updates Clinical Progress of CAR-NK Cell Therapy..
26/6/202315:01GLOBENkarta to Host Conference Call to Discuss Updated Clinical..
10/6/202309:47GLOBENkarta Presents NKX019 Clinical Data at the European..

Su Consulta Reciente

NASDAQ
NKTX
Nkarta
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados